How Advanced are Cancer Immuno-Nanotherapeutics? A Comprehensive Review of the Literature.

Abstract

Cancer is a broad term for a group of diseases involving uncontrolled cell growth and proliferation. There is no cure for cancer despite recent significant improvements in screening, treatment, and prevention approaches. Among the available treatments, immunotherapy has been successful in targeting and killing cancer cells by stimulating or enhancing the body's immune system. Antibody-based immunotherapeutic agents that block immune checkpoint proteins expressed by cancer cells have shown promising results. The rapid development of nanotechnology has contributed to improving the effectiveness and reducing the adverse effects of these anti-cancer immunotherapeutic agents. Recently, engineered nanomaterials have been the focus of many state-of-The-art approaches toward effective cancer treatment. In this review, the contribution of various nanomaterials such as polymeric nanoparticles, dendrimers, microspheres, and carbon nanomaterials in improving the efficiency of anti-cancer immunotherapy is discussed as well as nanostructures applied to combination cancer immunotherapy.

• Authors: Dhananjay Yadav, Nidhi Puranik, Anju Meshram, Vishal Chavda, Peter Chang-Whan Lee, Jun-O Jin
• Journal: International journal of nanomedicine (Int J Nanomedicine) Vol. 18 Pg. 35-48 ( 2023) ISSN: 1178-2013 [Electronic] New Zealand
• PMID: 36636642 (Publication Type: Journal Article, Review)
• Copyright: © 2023 Yadav et al.

Chemical References

• Antineoplastic Agents

Topics

• Humans
• Neoplasms (drug therapy)
• Antineoplastic Agents (therapeutic use)
• Nanotechnology (methods)
• Nanostructures (chemistry)
• Nanoparticles (therapeutic use)
• Immunotherapy (methods)